| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 12/19/2007 | CN101090715A Dendritic cell infiltrativity activating composition and immune activator |
| 12/19/2007 | CN101090711A Particles for treatment of pulmonary infection |
| 12/19/2007 | CN101089186A Expression carrier for human L-type complement agglutinant fibre gelled protein and construction and application |
| 12/19/2007 | CN101089004A New type of phosphonate-nucleotide compound |
| 12/19/2007 | CN101088561A Anti hepatitis c virus antibody and uses thereof |
| 12/19/2007 | CN101088559A Polyepitope tuberculosis gene vaccine and its prepn process |
| 12/19/2007 | CN101088558A Effervescent tablet of human interferon-alpha-2b and its prepn process |
| 12/19/2007 | CN101088557A Medicine composition for preventing and treating HIV infection and its application |
| 12/19/2007 | CN101088533A Antiviral Chinese medicine prepn and its prepn process, quality control method and application |
| 12/19/2007 | CN101088513A 生命技术及其应用 Life Technologies and Applications |
| 12/19/2007 | CN101088500A Cold treating medicine for children |
| 12/19/2007 | CN100355786C Polyethylene glycol-modified thymus peptide 1 derivatives |
| 12/19/2007 | CN100355777C Hepatitis B virus pre-S mutain, and its preparing process and application |
| 12/19/2007 | CN100355753C Tropan derivatives useful in therapy, method for obtaining thereof and intermediate compounds |
| 12/19/2007 | CN100355751C 2-substd. 4-heteroaryl-pyrimidines and their use in treatment of proliferative disorders |
| 12/19/2007 | CN100355729C Pleuromutilin |
| 12/19/2007 | CN100355457C Dispersible pharmaceutical compositions |
| 12/19/2007 | CN100355453C Improved vaccines |
| 12/19/2007 | CN100355446C Synergistic medicinal composition |
| 12/19/2007 | CN100355444C Health medicine for preventing cold |
| 12/19/2007 | CN100355439C Capsule for curing enteritis and bloody flux |
| 12/19/2007 | CN100355428C Preparation technology and use of Chinese herbal medicine phoenix-tail fern |
| 12/19/2007 | CN100355426C Disodium adenosine triphosphate solid composition for injection and its preparing method |
| 12/19/2007 | CN100355417C Formulation of 'Duyiwei' with improved bioavailability and drug effect and preparation process thereof |
| 12/18/2007 | US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 12/18/2007 | US7309790 Chemical compounds |
| 12/18/2007 | US7309782 Pure crystalline azithromycin monohydrate hemi-ethanol solvate; nuclear magnetic resonance spectrum analysis; bactericides; antiprotozoa agents; infections of mammals, birds and fish; drug resistance . |
| 12/18/2007 | US7309759 Indolicidin peptide analogues containing at least two basic amino acids; bactericide |
| 12/18/2007 | US7309721 Aminoalkylphosphonates and related compounds as Edg receptor agonists |
| 12/18/2007 | US7309598 gM-negative EHV-mutants |
| 12/18/2007 | US7309591 Method for the production of resveratrol in cell cultures |
| 12/18/2007 | US7309583 Nucleotide sequences coding polypeptide for use in the prevention of bacterial infection of mammals |
| 12/18/2007 | US7309494 Contains connecting disulfide bridge; humanized monoclonal and polyclonal antibodies; diagnostic kits for respiratory syncytial virus |
| 12/18/2007 | CA2462459C Copolymers for suppression of autoimmune diseases, and methods of use |
| 12/18/2007 | CA2418479C Prodrugs of betulinic acid derivatives for the treatment of cancer |
| 12/18/2007 | CA2378436C Method for producing antibiotic composites |
| 12/18/2007 | CA2103306C Extrudable compositions for topical or transdermal drug delivery |
| 12/13/2007 | WO2007143521A1 Cyclopropyl fused indolobenzazepine hcv inhibitors |
| 12/13/2007 | WO2007143446A1 Spiro-condensed heterotricyclic compounds as hiv integrase inhibitors |
| 12/13/2007 | WO2007142986A2 Aminothiazole derivatives and their uses as antibacterial agents |
| 12/13/2007 | WO2007142725A2 Combination of gyrase b inhibitors and protein synthesis inhibitors and uses thereof |
| 12/13/2007 | WO2007142323A1 Novel indazole derivative having spiro ring structure in side chain |
| 12/13/2007 | WO2007142304A1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 12/13/2007 | WO2007142253A1 2-cyanopyrrolidine derivative |
| 12/13/2007 | WO2007142212A1 Preparation composition |
| 12/13/2007 | WO2007142150A1 Novel aminoglycoside antibiotic |
| 12/13/2007 | WO2007141513A1 Use of coumarin derivatives in antifungal therapy |
| 12/13/2007 | WO2007141392A2 Compositions comprising betulonic acid |
| 12/13/2007 | WO2007141390A1 Betulin derived compounds useful as antiviral agents |
| 12/13/2007 | WO2007141389A1 Betulin derived compounds useful as antibacterial agents |
| 12/13/2007 | WO2007141315A1 Improved method of treatment of bacterial infections |
| 12/13/2007 | WO2007141274A2 Human binding molecules having killing activity against staphylococci and uses thereof |
| 12/13/2007 | WO2007140588A1 Pathogenic attenuation via the administration of an equilibiotic compound |
| 12/13/2007 | WO2007140525A1 A method of treatment and prophylaxis of events, conditions and diseases of the systemic vasculature an immune function to decrease cardiovascular risk and pathogenic infection |
| 12/13/2007 | WO2007109251A3 Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases |
| 12/13/2007 | WO2007105154A3 Antibiotic compounds |
| 12/13/2007 | WO2007093635A3 Proteasom or ups inhibitor for treating infections with influenza viruses |
| 12/13/2007 | WO2007041632A3 Methods and pharmaceutical compositions for the treatment and prevention of hepatitis c infection |
| 12/13/2007 | WO2006089942A8 Protease inhibitor precursor synthesis |
| 12/13/2007 | US20070287970 Method for systemic drug delivery through the nail |
| 12/13/2007 | US20070287826 Production of high molecular mass lectins |
| 12/13/2007 | US20070287735 Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| 12/13/2007 | US20070287730 useful for the treatment of HIV and AIDS |
| 12/13/2007 | US20070287725 Isoxazole, Dihydroisoxazole, And Oxadiazole Substituted Imidazo Ring Compounds And Method |
| 12/13/2007 | US20070287724 Substituted Imidazoquinolines, Imidazopyridines, and Imidazonaphthyridines |
| 12/13/2007 | US20070287721 Pyrazolopyridinyl pyridine |
| 12/13/2007 | US20070287712 antiviral agents for the treatment of HIV and AIDS; indole and azaindole piperazine enamine derivatives; 2-((4-(2-(4-fluoro-7-(1H-1,2,3-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoacetyl)piperazin-1-yl)(phenyl)methylene)malononitrile |
| 12/13/2007 | US20070287706 Certain substituted quinolones, compositions, and uses thereof |
| 12/13/2007 | US20070287702 Thioridazine And Derivatives Thereof For Reversing Anti-Microbial Drug-Resistance |
| 12/13/2007 | US20070287701 6-({[(1-{2-[6-(methyloxy)-1,5-naphthyridin-4-yl]ethyl}-3-pyrrolidinyl)methyl]amino}methyl)-2H-pyrido[3,2-b][1,4]thiazin-3(4H)-one; bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
| 12/13/2007 | US20070287700 Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 12/13/2007 | US20070287699 Antiviral agents |
| 12/13/2007 | US20070287675 Enhanced Delivery of Drug Compositions to Treat Life Threatening Infections |
| 12/13/2007 | US20070287664 Combinations of HCV protease inhibitor(s) and CYP3A4 inhibitor(s), and methods of treatment related thereto |
| 12/13/2007 | US20070287663 Glycopeptide Composition with Improved Antibiotic Activity |
| 12/13/2007 | US20070287662 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 12/13/2007 | US20070287632 Sulphur-Containing Oils For Controlling Plant Pathogens And Stimulating Nutrient Uptake |
| 12/13/2007 | US20070287173 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 12/13/2007 | US20070286901 Novel Pharmaceutical Formulation of Cefixime for Enhanced Bioavailability |
| 12/13/2007 | US20070286895 Wound dressing |
| 12/13/2007 | US20070286872 Live Attenuated Nidovirus Vaccines |
| 12/13/2007 | US20070286869 Influenza virus vaccine composition and methods of use |
| 12/13/2007 | US20070286843 Recombinant Polypeptides of the Members of the Tnf Ligand Family and Use Thereof |
| 12/13/2007 | US20070286842 serine protease inhibitors, for the treatment of hepatitis c virus infections |
| 12/13/2007 | DE102004040014B4 Aureonitrile, Verfahren zu ihrer Herstellung und ihre Verwendung Aureonitrile, processes for their preparation and their use |
| 12/13/2007 | CA2654712A1 Human binding molecules having killing activity against staphylococci and uses thereof |
| 12/13/2007 | CA2654561A1 Novel aminoglycoside antibiotics |
| 12/13/2007 | CA2654509A1 Use of time-dependent antibiotics in the treatment of bacterial infections |
| 12/13/2007 | CA2654370A1 Use of coumarin derivatives in antifungal therapy |
| 12/13/2007 | CA2654352A1 Compositions comprising betulonic acid |
| 12/13/2007 | CA2654082A1 Use of micron-sized sulphur for the prevention and treatment of pathogenic disorders in humans and animals |
| 12/13/2007 | CA2653833A1 Isolated extract of walnuts, process for its obtention and its use |
| 12/13/2007 | CA2653424A1 Novel indazole derivative having spiro ring structure in side chain |
| 12/13/2007 | CA2650133A1 Aminothiazole derivatives and their uses as antibacterial agents |
| 12/13/2007 | CA2636288A1 Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists |
| 12/12/2007 | EP1865065A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 12/12/2007 | EP1865055A1 Component of bromelain |
| 12/12/2007 | EP1864985A1 Novel carbapenem compound |
| 12/12/2007 | EP1864980A1 Antifungal agent containing pyridine derivative |
| 12/12/2007 | EP1864975A2 Novel compounds |